Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Notable: Non-invasive Device · Open Abdomen (AbCLO) Primary completion date changed from estimate of Dec 31, 2025 to Oct 30, 2026
- Notable: Use of Equity Report Cards to Mitigate Disparities in Emergency Medical Services (EMS) Care for Injured Children Primary completion date changed from estimate of Dec 2025 to Jul 31, 2026
- Notable: Safer Personalised Cancer Treatment Digital Follow-up Primary completion date changed from estimate of Jun 1, 2025 to Dec 30, 2025
- Notable: Periodontitis · Osteoarthritis Eligibility criteria changed
- Notable: Dynamic Relationships Between Estrogen Fluctuations, Sleep, and Psychiatric Complexity Among Adolescent Females With ADHD Start date pushed from Sep 2026 to Dec 2026
- Notable: Interventions for Health Behaviors in Hypertensive Patients Primary completion date changed from estimate of May 2025 to Dec 31, 2025
- Notable: Web-Based Education on Attitudes and Beliefs About HPV Testing Start date pushed from Nov 1, 2026 to Dec 1, 2026
- Notable: Electrical Brain Stimulation for College Students With Short-Form Video Addiction: Effects and Mechanisms Eligibility criteria changed
- Notable: Quality of Life and Economic Repercussions of Combining Proactive Medication Assessment and Electronic Monitoring of Toxicities in Subjects Undergoing Oral Cancer Therapy Primary completion date changed from estimate of Oct 2025 to Oct 7, 2026
- Notable: Micronutrient Supplementation With Digital Layering Among Adolescents in Tanzania Start date pushed from Oct 7, 2026 to Dec 1, 2026
- Notable: Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic Shock Start date pushed from Oct 31, 2026 to May 1, 2027
- Notable: Perceptions of and Reactions to Sustainability Menu Label Designs Results posted: Nov 16, 2026
- Notable: CICAPLAST BAUME B5+ on Rosacea Accompanied by Sensitive Skin Results posted: Nov 16, 2026
- Minor: Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL Trial completed
- Minor: IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Minor: Mesothelin-Targeting Logic-gated CAR T, · Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression Enrollment closed, study ongoing
- Minor: SIM0278 · Moderate to Severe Atopic Dermatitis Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Minor: MAXPIRe · Axatilimab · Idiopathic Pulmonary Fibrosis (IPF) Trial completed
- Minor: RGX-314 Gene Therapy Administered in the Suprachoroidal Space · Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME) Trial completed
- Minor: FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) Trial completed
- Minor: LY4268989 (MORF 057) in Healthy Participants Trial completed
- Minor: Research Into the Safety of a New Agent (VT-5006) · and Without Parkinson's Disease Trial completed
- Minor: IBI3011 Trial completed
- Minor: Cardiac Performance System (CPS) Trial completed
- Minor: Vimida Trial completed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates